
Mikacore 500mg Injection
Marketer
Biocore Pharmaceuticals
Salt Composition
Amikacin (500mg)
Overview Mikacore 500mg Injection
Cefamika 500mg injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, musculoskeletal system, respiratory system (such as pneumonia), central nervous system, and bloodstream. It's also prophylactically administered to hospitalized individuals to preempt infection. This antibiotic functions by inhibiting bacterial proliferation. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional only, it necessitates regular dosing at prescribed intervals. Complete the entire course, even with symptom improvement, as premature cessation risks relapse or complication. Common adverse effects include injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or treatment inefficacy warrant immediate medical consultation. High-dose therapy may result in vertigo, nephrotoxicity, and ototoxicity; hence, strict adherence to physician instructions is crucial, including scheduled kidney function, hearing, and urinalysis. This medication is contraindicated in pregnancy. Disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Mikacore 500mg Injection
Infections caused by bacteria
Major Benefits of Mikacore 500mg Injection:
Administering this medication will be handled by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Mikacore 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikacore 500mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mikacore 500mg Injection works:
Mikacore 500mg injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Mikacore 500mg Injection taken with alcohol shows no evidence of adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikacore 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikacore 500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
The administration of Mikacore 500mg Injection can lead to reduced awareness, impaired vision, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administration of Mikacore 500mg Injection requires careful monitoring. Dosage modification of Mikacore 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mikacore 500mg Injection in patients with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Mikacore 500mg Injection :
Omitting a scheduled Mikacore 500mg Injection requires contacting your physician.
Facts to Know About Mikacore 500mg Injection
| Label | Value |
|---|---|
| Pharmacological Category | Aminoglycoside antibiotics |
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
| Mechanism of Action | Aminoglycoside antibiotics |
